Their explanation for this attenuated GVHD was that STAT1-deficient CD9–SiglecHhi donor plasmacytoid DCs (pDCs) were tolerogenic and crucial for the reduced induction of GVHD (61) through increased IL-10 and reduced IL-12 and IFN-α production. Here, CD9 is linked to graft versus host disease.